Literature DB >> 26850527

The Matrix Metalloproteinase 9 Point-of-Care Test in Dry Eye.

Nicole L Lanza1, Felipe Valenzuela2, Victor L Perez3, Anat Galor4.   

Abstract

Dry eye is a common, multifactorial disease currently diagnosed by a combination of symptoms and signs. However, the subjective symptoms of dry eye poorly correlate to the current gold standard for diagnostic tests, reflecting the need to develop better objective tests for the diagnosis of dry eye. This review considers the role of ocular surface matrix metalloproteinase 9 (MMP-9) in dry eye and the implications of a novel point-of-care test that measures MMP-9 levels, InflammaDry (RPS, Sarasota, FL) on choosing appropriate therapeutic treatments. Published by Elsevier Inc.

Entities:  

Keywords:  InflammaDry; dry eye; matrix metalloproteinase 9

Mesh：

Substances：

Year:  2016        PMID： 26850527      PMCID： PMC5580996          DOI： 10.1016/j.jtos.2015.10.004

Source DB:  PubMed          Journal:  Ocul Surf        ISSN： 1542-0124            Impact factor:   5.033


  49 in total

Review 1.  Effect of inflammation on lacrimal gland function.

Authors:  Driss Zoukhri
Journal:  Exp Eye Res       Date:  2005-11-23       Impact factor: 3.467

2.  Desiccating stress stimulates expression of matrix metalloproteinases by the corneal epithelium.

Authors:  Rosa M Corrales; Michael E Stern; Cintia S De Paiva; Jonathan Welch; De-Quan Li; Stephen C Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-08       Impact factor: 4.799

3.  Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant.

Authors:  L Sobrin; Z Liu; D C Monroy; A Solomon; M G Selzer; B L Lokeshwar; S C Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-06       Impact factor: 4.799

4.  Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes.

Authors:  K S Kunert; A S Tisdale; M E Stern; J A Smith; I K Gipson
Journal:  Arch Ophthalmol       Date:  2000-11

5.  Dysfunctional tear syndrome: a Delphi approach to treatment recommendations.

Authors:  Ashley Behrens; John J Doyle; Lee Stern; Roy S Chuck; Peter J McDonnell; Dimitri T Azar; Harminder S Dua; Milton Hom; Paul M Karpecki; Peter R Laibson; Michael A Lemp; David M Meisler; Juan Murube Del Castillo; Terrence P O'Brien; Stephen C Pflugfelder; Maurizio Rolando; Oliver D Schein; Berthold Seitz; Scheffer C Tseng; Gysbert van Setten; Steven E Wilson; Samuel C Yiu
Journal:  Cornea       Date:  2006-09       Impact factor: 2.651

6.  Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group.

Authors:  K Sall; O D Stevenson; T K Mundorf; B L Reis
Journal:  Ophthalmology       Date:  2000-04       Impact factor: 12.079

7.  IL-1 beta promotes A549 cell migration via MAPKs/AP-1- and NF-kappaB-dependent matrix metalloproteinase-9 expression.

Authors:  Chih-Chung Lin; Chang-Ting Kuo; Ching-Yi Cheng; Cheng-Ying Wu; Chiang-Wen Lee; Hsi-Lung Hsieh; I-Ta Lee; Chuen-Mao Yang
Journal:  Cell Signal       Date:  2009-07-16       Impact factor: 4.315

8.  Comparison of the effects of latanoprost and bimatoprost on central corneal thickness.

Authors:  Emine Sen; Pinar Nalcacioglu; Alper Yazici; Fatma Nur Aksakal; Ayse Altinok; Tulay Tuna; Gultekin Koklu
Journal:  J Glaucoma       Date:  2008-08       Impact factor: 2.503

9.  Prospective, multicenter, clinical evaluation of point-of-care matrix metalloproteinase-9 test for confirming dry eye disease.

Authors:  Robert Sambursky; William F Davitt; Murray Friedberg; Shachar Tauber
Journal:  Cornea       Date:  2014-08       Impact factor: 2.651

10.  IL-1β promotes corneal epithelial cell migration by increasing MMP-9 expression through NF-κB- and AP-1-dependent pathways.

Authors:  Hui-Ching Tseng; I-Ta Lee; Chih-Chung Lin; Pei-Ling Chi; Shin-Ei Cheng; Ruey-Horng Shih; Li-Der Hsiao; Chuen-Mao Yang
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240
View more
  26 in total

1.  Dry Eye Symptoms and Signs in US Veterans With Gulf War Illness.

Authors:  Victor Sanchez; Brandon S Baksh; Kimberly Cabrera; Anjalee Choudhury; Katherine Jensen; Nancy Klimas; Anat Galor
Journal:  Am J Ophthalmol       Date:  2021-11-13       Impact factor: 5.258

2.  Elevation of Tear MMP-9 Concentration as a Biomarker of Inflammation in Ocular Pathology by Antibody Microarray Immunodetection Assays.

Authors:  Miguel de la Fuente; Iñaki Rodríguez-Agirretxe; Elena Vecino; Egoitz Astigarraga; Arantxa Acera; Gabriel Barreda-Gómez
Journal:  Int J Mol Sci       Date:  2022-05-18       Impact factor: 6.208

Review 3.  Lab-on-a-Contact Lens: Recent Advances and Future Opportunities in Diagnostics and Therapeutics.

Authors:  Yangzhi Zhu; Shaopei Li; Jinghang Li; Natashya Falcone; Qingyu Cui; Shilp Shah; Martin C Hartel; Ning Yu; Patric Young; Natan Roberto de Barros; Zhuohong Wu; Reihaneh Haghniaz; Menekse Ermis; Canran Wang; Heemin Kang; Junmin Lee; Solmaz Karamikamkar; Samad Ahadian; Vadim Jucaud; Mehmet R Dokmeci; Han-Jun Kim; Ali Khademhosseini
Journal:  Adv Mater       Date:  2022-04-11       Impact factor: 32.086

4.  Dry Eye Profiles in Patients with a Positive Elevated Surface Matrix Metalloproteinase 9 Point-of-Care Test Versus Negative Patients.

Authors:  Nicole L Lanza; Allison L McClellan; Hatim Batawi; Elizabeth R Felix; Konstantinos D Sarantopoulos; Roy C Levitt; Anat Galor
Journal:  Ocul Surf       Date:  2016-01-22       Impact factor: 5.033

5.  Diagnostic tests in dry eye.

Authors:  Amy Kloosterboer; Harrison Isaac Dermer; Anat Galor
Journal:  Expert Rev Ophthalmol       Date:  2019-08-29

6.  Fecal Microbial Transplant in Individuals With Immune-Mediated Dry Eye.

Authors:  Arjun Watane; Kara M Cavuoto; Mario Rojas; Harrison Dermer; Joanne O Day; Santanu Banerjee; Anat Galor
Journal:  Am J Ophthalmol       Date:  2021-06-30       Impact factor: 5.258

Review 7.  Alternative therapies for dry eye disease.

Authors:  Rhiya Mittal; Sneh Patel; Anat Galor
Journal:  Curr Opin Ophthalmol       Date:  2021-07-01       Impact factor: 4.299

8.  Development towards Compact Nitrocellulose-Based Interferometric Biochips for Dry Eye MMP9 Label-Free In-Situ Diagnosis.

Authors:  Beatriz Santamaría; María F Laguna; David López-Romero; Ana L Hernandez; Francisco J Sanza; Álvaro Lavín; Rafael Casquel; María V Maigler; Rocío L Espinosa; Miguel Holgado
Journal:  Sensors (Basel)       Date:  2017-05-19       Impact factor: 3.576

Review 9.  Dry eye syndrome: developments and lifitegrast in perspective.

Authors:  Ivonne V Lollett; Anat Galor
Journal:  Clin Ophthalmol       Date:  2018-01-15

10.  Parallel ocular and serologic course in a patient with early Sjogren's syndrome markers.

Authors:  Lam Phung; Ivonne V Lollett; Raquel Goldhardt; Janet L Davis; Larry Young; Dana Ascherman; Anat Galor
Journal:  Am J Ophthalmol Case Rep       Date:  2017-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.